Jazz Pharmaceuticals (JAZZ) Share-based Compensation Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.65% |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | 9.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.75% |
| Dec 31, 2025 | 4.80% |
| Sep 30, 2025 | 15.85% |
| Jun 30, 2025 | 6.28% |
| Mar 31, 2025 | 10.58% |
| Dec 31, 2024 | 9.73% |
| Sep 30, 2024 | 3.93% |
| Jun 30, 2024 | 5.56% |
| Mar 31, 2024 | 21.23% |
| Dec 31, 2023 | 19.04% |
| Sep 30, 2023 | 22.73% |
| Jun 30, 2023 | 26.15% |
| Mar 31, 2023 | 25.29% |
| Dec 31, 2022 | 33.39% |
| Sep 30, 2022 | 25.34% |
| Jun 30, 2022 | 23.81% |
| Mar 31, 2022 | 22.03% |
| Dec 31, 2021 | 25.73% |
| Sep 30, 2021 | 28.48% |
| Jun 30, 2021 | 22.33% |
| Mar 31, 2021 | 12.37% |
| Dec 31, 2020 | 4.73% |
| Sep 30, 2020 | 3.82% |
| Jun 30, 2020 | 3.93% |
| Mar 31, 2020 | 4.38% |
| Dec 31, 2019 | 2.22% |
| Sep 30, 2019 | 4.99% |
| Jun 30, 2019 | 3.61% |
| Mar 31, 2019 | 4.44% |
| Dec 31, 2018 | 3.19% |
| Sep 30, 2018 | 2.79% |
| Jun 30, 2018 | 4.14% |
| Mar 31, 2018 | 5.29% |
| Dec 31, 2017 | 12.83% |
| Sep 30, 2017 | 14.12% |
| Jun 30, 2017 | 13.69% |
| Mar 31, 2017 | 22.17% |
| Sep 30, 2016 | -8.19% |
| Jun 30, 2016 | 7.87% |
| Mar 31, 2016 | 40.30% |
| Dec 31, 2015 | 45.74% |
| Sep 30, 2015 | 51.77% |
| Jun 30, 2015 | 64.25% |
| Mar 31, 2015 | 85.13% |
| Dec 31, 2014 | 37.60% |
| Sep 30, 2014 | 78.76% |
| Jun 30, 2014 | 75.79% |
| Mar 31, 2014 | 63.72% |
| Sep 30, 2013 | 145.32% |